CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Arsanis, Inc.

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Nov 1, 2016

Acquired by X4 Pharmaceuticals on Mar 14, 2019

Timeline

2010s

Jun 1, 2010
Arsanis, Inc.— Founded
Jun 1, 2014
X4 PHARMS— Acquired
Mar 14, 2019
X4 Pharmaceuticals— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

fontolizumab

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

X4 PHARMS

Recent trials (2)

NCT02940626Study directorPhase 2Nov 1, 2016
NCT02940626Lead sponsorPhase 2Nov 1, 2016

Details

Founded: Vienna, AT Jun 1, 2010
Last known activity: Nov 1, 2016